[Comparative analysis of Hancock and St. Jude Medical valve after mitral valve replacement]. 1991

T Kazui, and A Watanabe, and M Morikawa, and H Kawamura, and M Inaoka, and T Yamaguchi, and O Yamada, and S Komatsu
Department of Surgery (Section 2), Sapporo Medical College & Hospital, Japan.

Long term results were compared in 81 operative survivors with MVR using Hancock valve (Hancock group) and 83 using St. Jude Medical valve (SJM group). The cumulative follow-up was 709.0 patients-year (p-y) and 175.2 p-y in the Hancock and SJM groups. Twenty-four percent of the patients in the Hancock group was permanently anticoagulated, while 100% of patients in the SJM group anticoagulated. The 7-year actuarial survival rate including early mortality was 79.3 +/- 4.6% for the Hancock and 93.9 +/- 3.0% for the SJM group (p less than 0.01). The survival rate was significantly higher in the SJM group than that in the Hancock group. The 7-year actuarial event free rate of the valve-related complications in the Hancock and SJM groups were as follows; thromboembolism 88.6 +/- 3.8% vs 95.0 +/- 2.8% (NS), hemorrhage, 94.0 +/- 3.0% vs 98.7 +/- 1.8% (NS), paravalvular leak 92.6 +/- 3.2% vs 97.4 +/- 1.8% (NS), infection 93.9 +/- 3.0% vs 100% (p less than 0.05), valve malfunction 78.0 +/- 5.2% vs 100% (p less than 0.001), overall valve related complications 58.9 +/- 5.9% vs 91.1 +/- 3.5% (p less than 0.001), reoperation for valve-related complication 83.1 +/- 4.6% vs 100% (p less than 0.01). The event free rate of reoperation for valve related complication in the Hancock group was significantly lower than that in the SJM group. The Hancock valve had the acceptable antithrombogenicity, but had the limited long-term durability.(ABSTRACT TRUNCATED AT 250 WORDS)

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D008943 Mitral Valve The valve between the left atrium and left ventricle of the heart. Bicuspid Valve,Bicuspid Valves,Mitral Valves,Valve, Bicuspid,Valve, Mitral,Valves, Bicuspid,Valves, Mitral
D008944 Mitral Valve Insufficiency Backflow of blood from the LEFT VENTRICLE into the LEFT ATRIUM due to imperfect closure of the MITRAL VALVE. This can lead to mitral valve regurgitation. Mitral Incompetence,Mitral Regurgitation,Mitral Valve Incompetence,Mitral Insufficiency,Mitral Valve Regurgitation,Incompetence, Mitral,Incompetence, Mitral Valve,Insufficiency, Mitral,Insufficiency, Mitral Valve,Regurgitation, Mitral,Regurgitation, Mitral Valve,Valve Incompetence, Mitral,Valve Insufficiency, Mitral,Valve Regurgitation, Mitral
D005260 Female Females
D005500 Follow-Up Studies Studies in which individuals or populations are followed to assess the outcome of exposures, procedures, or effects of a characteristic, e.g., occurrence of disease. Followup Studies,Follow Up Studies,Follow-Up Study,Followup Study,Studies, Follow-Up,Studies, Followup,Study, Follow-Up,Study, Followup
D006350 Heart Valve Prosthesis A device that substitutes for a heart valve. It may be composed of biological material (BIOPROSTHESIS) and/or synthetic material. Prosthesis, Heart Valve,Cardiac Valve Prosthesis,Cardiac Valve Prostheses,Heart Valve Prostheses,Prostheses, Cardiac Valve,Prostheses, Heart Valve,Prosthesis, Cardiac Valve,Valve Prostheses, Cardiac,Valve Prostheses, Heart,Valve Prosthesis, Cardiac,Valve Prosthesis, Heart
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D001705 Bioprosthesis Prosthesis, usually heart valve, composed of biological material and whose durability depends upon the stability of the material after pretreatment, rather than regeneration by host cell ingrowth. Durability is achieved 1, mechanically by the interposition of a cloth, usually polytetrafluoroethylene, between the host and the graft, and 2, chemically by stabilization of the tissue by intermolecular linking, usually with glutaraldehyde, after removal of antigenic components, or the use of reconstituted and restructured biopolymers. Glutaraldehyde-Stabilized Grafts,Heterograft Bioprosthesis,Porcine Xenograft Bioprosthesis,Xenograft Bioprosthesis,Bioprostheses,Bioprostheses, Heterograft,Bioprostheses, Porcine Xenograft,Bioprostheses, Xenograft,Bioprosthesis, Heterograft,Bioprosthesis, Porcine Xenograft,Bioprosthesis, Xenograft,Glutaraldehyde Stabilized Grafts,Glutaraldehyde-Stabilized Graft,Graft, Glutaraldehyde-Stabilized,Grafts, Glutaraldehyde-Stabilized,Heterograft Bioprostheses,Porcine Xenograft Bioprostheses,Xenograft Bioprostheses,Xenograft Bioprostheses, Porcine,Xenograft Bioprosthesis, Porcine

Related Publications

T Kazui, and A Watanabe, and M Morikawa, and H Kawamura, and M Inaoka, and T Yamaguchi, and O Yamada, and S Komatsu
December 1994, The Annals of thoracic surgery,
T Kazui, and A Watanabe, and M Morikawa, and H Kawamura, and M Inaoka, and T Yamaguchi, and O Yamada, and S Komatsu
March 1994, Journal of the American College of Cardiology,
T Kazui, and A Watanabe, and M Morikawa, and H Kawamura, and M Inaoka, and T Yamaguchi, and O Yamada, and S Komatsu
June 1984, Annals of surgery,
T Kazui, and A Watanabe, and M Morikawa, and H Kawamura, and M Inaoka, and T Yamaguchi, and O Yamada, and S Komatsu
June 2001, Kyobu geka. The Japanese journal of thoracic surgery,
T Kazui, and A Watanabe, and M Morikawa, and H Kawamura, and M Inaoka, and T Yamaguchi, and O Yamada, and S Komatsu
January 1981, Kyobu geka. The Japanese journal of thoracic surgery,
T Kazui, and A Watanabe, and M Morikawa, and H Kawamura, and M Inaoka, and T Yamaguchi, and O Yamada, and S Komatsu
December 1989, British heart journal,
T Kazui, and A Watanabe, and M Morikawa, and H Kawamura, and M Inaoka, and T Yamaguchi, and O Yamada, and S Komatsu
July 1990, British heart journal,
T Kazui, and A Watanabe, and M Morikawa, and H Kawamura, and M Inaoka, and T Yamaguchi, and O Yamada, and S Komatsu
August 1991, [Zasshi] [Journal]. Nihon Kyobu Geka Gakkai,
T Kazui, and A Watanabe, and M Morikawa, and H Kawamura, and M Inaoka, and T Yamaguchi, and O Yamada, and S Komatsu
August 2020, Journal of cardiac surgery,
T Kazui, and A Watanabe, and M Morikawa, and H Kawamura, and M Inaoka, and T Yamaguchi, and O Yamada, and S Komatsu
January 1994, Surgery today,
Copied contents to your clipboard!